Gambaran Umum
Oculis Holding AG is a biopharmaceutical company based in Switzerland, primarily engaged in the development of treatments for ophthalmic diseases. With a strong focus on innovation in ocular therapies, the company aims to address the unmet needs of patients suffering from eye conditions. Among its notable projects, Oculis is pioneering technologies to enhance the delivery of drugs directly to the eye, potentially offering non-invasive alternatives to current treatments that often require injections. Key areas of their research include therapies for diabetic macular edema and other severe eye diseases, positioning them at the forefront of ocular therapeutic development in the biopharmaceutical industry.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Oculis Holding AG per 2025 Jun 30 adalah 0.76 MM.
- Nilai operating income untuk Oculis Holding AG per 2025 Jun 30 adalah -76.13 MM.
- Nilai net income untuk Oculis Holding AG per 2025 Jun 30 adalah -107.43 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 0.76 | -76.13 | -107.43 |
| 2025-03-31 | 0.75 | -77.85 | -102.90 |
| 2024-12-31 | 0.69 | -73.20 | -85.78 |
| 2024-09-30 | 0.87 | -68.13 | -69.62 |
| 2024-06-30 | 0.87 | -62.96 | -66.84 |
| 2024-03-31 | 0.88 | -51.22 | -58.88 |
| 2023-12-31 | 0.88 | -45.85 | -88.80 |
| 2023-09-30 | 0.91 | -44.78 | -85.49 |
| 2023-06-30 | 0.90 | -38.69 | -78.03 |
| 2023-03-31 | 0.89 | -35.14 | -74.93 |
| 2022-12-31 | 0.91 | -32.38 | -38.70 |
| 2022-09-30 | 1.08 | -25.95 | -35.06 |
| 2021-12-31 | 0.96 | -13.23 | -18.55 |
| 2020-12-31 | 0.99 | -12.34 | -14.87 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | -2.12 | |
| 2024-09-30 | -1.79 | -1.79 |
| 2024-06-30 | -1.78 | -1.78 |
| 2024-03-31 | -1.64 | -1.64 |
| 2023-12-31 | -2.97 | |
| 2023-09-30 | -3.95 | -3.95 |
| 2023-06-30 | -5.83 | -5.83 |
| 2023-03-31 | -12.92 | -12.92 |
| 2022-12-31 | -11.32 | |
| 2022-09-30 | -10.80 | -10.80 |
| 2021-12-31 | -5.84 | |
| 2020-12-31 | -5.77 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Oculis Holding AG per 2025 Jun 30 adalah -56.24 MM.
- Nilai cash from investing activities untuk Oculis Holding AG per 2025 Jun 30 adalah -23.45 MM.
- Nilai kas dari aktivitas pendanaan untuk Oculis Holding AG per 2025 Jun 30 adalah 106.45 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | -56.24 | -23.45 | 106.45 |
| 2025-03-31 | -52.74 | -67.55 | 157.69 |
| 2024-12-31 | -47.50 | -17.56 | 54.03 |
| 2024-09-30 | -50.91 | 6.04 | 51.76 |
| 2024-06-30 | -52.46 | -1.94 | 52.94 |
| 2024-03-31 | -51.95 | -55.72 | 34.57 |
| 2023-12-31 | -53.84 | -54.21 | 129.67 |
| 2023-09-30 | -47.36 | -77.43 | 128.93 |
| 2023-06-30 | -42.31 | -74.13 | 130.43 |
| 2023-03-31 | -34.89 | -2.79 | 96.97 |
| 2022-12-31 | -25.07 | -3.55 | 1.71 |
| 2022-09-30 | -21.93 | -2.05 | 5.51 |
| 2021-12-31 | -13.82 | -0.03 | 55.19 |
| 2020-12-31 | -12.03 | -0.02 | 4.86 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2021-12-31 | |||
| 2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2021-12-31 | 0.00 | 0.00 |
| 2020-12-31 |
Efektivitas Manajemen
- roa untuk Oculis Holding AG pada 2025 Jun 30 adalah -0.74.
- roe untuk Oculis Holding AG pada 2025 Jun 30 adalah -0.95.
- roic untuk Oculis Holding AG pada 2025 Jun 30 adalah -0.63.
- croic untuk Oculis Holding AG pada 2025 Jun 30 adalah 0.22.
- ocroic untuk Oculis Holding AG pada 2025 Jun 30 adalah -0.32.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | -0.74 | -0.95 | -0.63 | 0.22 | -0.32 |
| 2025-03-31 | -0.87 | -1.30 | -1.15 | -0.14 | -0.64 |
| 2024-12-31 | -0.54 | -0.66 | -0.72 | 0.05 | -0.52 |
| 2024-09-30 | -0.52 | -0.66 | -0.59 | 0.02 | -0.45 |
| 2024-06-30 | -1.59 | -0.74 | -0.91 | -0.65 | |
| 2024-03-31 | -2.40 | -0.94 | 0.20 | -0.57 | |
| 2023-12-31 | -1.94 | -0.80 | 0.02 | -0.45 | |
| 2023-09-30 | -0.66 | 0.07 | -0.36 | ||
| 2023-06-30 | -1.34 | -0.32 | 0.03 | -0.18 | |
| 2023-03-31 | -1.29 | -2.99 | 2.25 | -1.39 | |
| 2022-12-31 | -0.96 | -0.47 | -0.60 | ||
| 2022-09-30 | -0.96 | -0.47 | -0.60 | ||
| 2021-12-31 | |||||
| 2020-12-31 |
Gross Margins
- marjin kotor untuk Oculis Holding AG pada 2025 Jun 30 adalah -73.76.
- marjin bersih untuk Oculis Holding AG pada 2025 Jun 30 adalah -137.38.
- marjin operasi untuk Oculis Holding AG pada 2025 Jun 30 adalah -103.94.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | -73.76 | -137.38 | -103.94 |
| 2025-03-31 | -74.92 | -125.04 | -106.71 |
| 2024-12-31 | -54.70 | -80.21 | -78.49 |
| 2024-09-30 | -49.77 | -76.74 | -72.28 |
| 2024-06-30 | -37.76 | -67.21 | -58.47 |
| 2024-03-31 | -32.12 | -100.57 | -51.93 |
| 2023-12-31 | -29.82 | -93.73 | -49.10 |
| 2023-09-30 | -25.62 | -87.18 | -43.23 |
| 2023-06-30 | -25.62 | -87.18 | -43.23 |
| 2023-03-31 | -24.76 | -83.91 | -39.35 |
| 2022-12-31 | -16.39 | -32.32 | -23.91 |
| 2022-09-30 | -16.39 | -32.32 | -23.91 |
| 2021-12-31 | |||
| 2020-12-31 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) | 1953530 |
Grupong Pang-industriya
| SIC 2834 - Pharmaceutical Preparations |
